S
CLLS

SignatureFD’s Cellectis CLLS Stock Holding History

SignatureFD’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-662
Closed -$3.2K – 3503
2025
Q4 		$3.2K Buy
+662
New +$2.77K ﹤0.01% 2834
2022
Q1 		– Sell
-3,801
Closed -$31K – 3166
2021
Q4 		$31K Buy
3,801
+3,475
+1,066% +$34.2K ﹤0.01% 1567
2021
Q3 		$4K Buy
326
+293
+888% +$4.06K ﹤0.01% 2418
2021
Q2 		$1K Buy
+33
New +$555 ﹤0.01% 2697
2020
Q4 		– Sell
-41
Closed -$1K – 2569
2020
Q3 		$1K Buy
+41
New +$727 ﹤0.01% 2383
2020
Q2 		– Sell
-313
Closed -$3K – 2512
2020
Q1 		$3K Buy
+313
New +$4.67K ﹤0.01% 1803

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SignatureFD's CLLS Position: Q1 2026 in Review

SignatureFD sold out of Cellectis (CLLS) in Q1 2026, closing a stake of 662 shares — an estimated $3.2K sold.

SignatureFD first reported a position in CLLS in Q1 2020 and held it in 6 quarters. The position peaked at $31K in Q4 2021. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • SignatureFD reported no remaining Cellectis position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 662 Cellectis shares in Q1 2026, an estimated $3.2K.
  • SignatureFD first reported a position in Cellectis in Q1 2020 and held it in 6 quarters.
  • SignatureFD's Cellectis position peaked at $31K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.